Insulin-like growth factor-I and its association with binding proteins in bovine milk

1989 ◽  
Vol 120 (1) ◽  
pp. 21-29 ◽  
Author(s):  
P. G. Campbell ◽  
C. R. Baumrucker

ABSTRACT Immunoreactive insulin-like growth factor-I (IGF-I) in bovine milk was quantified. IGF-I was principally association with an ∼45 kDa binding protein. In addition, a small fraction of IGF-I occurred at a molecular weight approximately the same as that of unbound IGF-I. Available binding sites existed on the ∼45 kDa binding protein. Bound IGF-I was readily dissociated from binding protein by acid treatment. When IGF-I was estimated in milk obtained from primiparous and multiparous cows, multiparous cows had a higher concentration (40 μmol/l) at parturition than primiparous cows (19·2 μmol/l). By day 2 of lactation, IGF-I concentrations were 30 and 50% of initial estimates for multiparous and primiparous cows respectively. The final IGF-I concentration, on day 56 of lactation, was 4·5 μmol/l for combined parity groups. At parturition in multiparous cows, the mass of IGF-I was estimated at 183 and 157 μmol for blood and milk pools respectively. Milk, therefore, represents a substantial pool of IGF-I in the cow. The mechanism of the appearance of IGF-I in bovine milk is unknown. Journal of Endocrinology (1989) 120, 21–29

1991 ◽  
Vol 261 (1) ◽  
pp. F22-F28 ◽  
Author(s):  
S. Kobayashi ◽  
D. R. Clemmons ◽  
M. A. Venkatachalam

We report the localization of insulin-like growth factor I (IGF-I) and a 25-kDa form of insulin-like growth factor-binding protein (IGF-BP-1) in adult rat kidney. The antigens were localized using a rabbit anti-human IGF-I antibody, and a rabbit anti-human IGF-BP-1 antibody raised against human 25-kDa IGF-BP-1 purified from amniotic fluid. Immunohistochemistry by the avidin-biotin peroxidase conjugate technique showed that both peptides are located in the same nephron segments, in the same cell types. The most intense staining was in papillary collecting ducts. There was moderate staining also in cortical collecting ducts and medullary thick ascending limbs of Henle's loop. In collecting ducts the antigens were shown to be present in principal cells but not in intercalated cells. In distal convoluted tubules, cortical thick ascending limbs, and in structures presumptively identified as thin limbs of Henle's loops there was only modest staining. The macula densa, however, lacked immunoreactivity. Colocalization of IGF-I and IGF-BP-1 in the same cells supports the notion, derived from studies on cultured cells, that the actions of IGF-I may be modified by IGF-BPs that are present in the same location.


1998 ◽  
Vol 83 (10) ◽  
pp. 3550-3557 ◽  
Author(s):  
A. L. Ogilvy-Stuart ◽  
S. J. Hands ◽  
C. J. Adcock ◽  
J. M. P. Holly ◽  
D. R. Matthews ◽  
...  

1998 ◽  
Vol 30 (Supplement) ◽  
pp. 173
Author(s):  
R. C. Hickson ◽  
L. P. Koziris ◽  
R. T. Chatterton ◽  
R. T. Groseth ◽  
J. M. Christie ◽  
...  

1989 ◽  
Vol 123 (3) ◽  
pp. 469-475 ◽  
Author(s):  
S. R. Davis ◽  
S. C. Hodgkinson ◽  
L. G. Moore ◽  
P. D. Gluckman

ABSTRACT Clearance of protein-bound forms of insulin-like growth factor-I (IGF-I) from the circulation of sheep was determined using single injections of 131I-labelled ovine or [Thr59]-human IGF-I, in the 'free' form or prebound to 50 or 150 kDa plasma binding protein fractions. The half-life of circulating protein-bound forms of IGF-I was determined by size-exclusion chromatography of plasma samples taken over a 24-to 26-h experimental period. IGF-I bound to lower molecular weight binding protein(s) (approximately 50 kDa) showed a half-life of 26–40 min (mean 34 min; n = 6), while the half-life of a high molecular weight fraction (150 kDa) was considerably longer (range 398–603 min; mean 545 min; n =8). Metabolic clearance of IGF-I following administration of free tracer ranged from 3.0 to 5.3 ml/min in sheep (n = 4) weighing 26.0–28.5 kg. Tracer distribution volume was 59 ml/kg liveweight (n=4). Tracer degradation products were first detected in plasma 8 h after i.v. administration. No differences in stability of the purified ovine and recombinant human IGF-I tracer preparations were observed. However, a fraction of the [Thr59]-IGF-I tracer did not possess binding activity and this was associated with excretion of a greater proportion of administered radioactivity (over 22 h) in urine in animals receiving [Thr59]-IGF-I tracer (18.4–19.3%) compared with ovine IGF-I (7.1–11.0%). Following administration of free tracer or tracer bound to the 50 kDa protein, the proportion of radioactivity bound to the 150 kDa fraction increased over the first 20-30 min of observation. However, this was not apparent following administration of tracer bound to the 150 kDa protein, indicating that the more rapid turnover of IGF-I bound to the 50 kDa protein was associated, in part, with transfer of IGF-I to the 150 kDa binding protein fraction. The calculated secretion rates of the IGFs were two- to threefold and twentyfold higher, for IGF-I and -II respectively, relative to that of insulin. These data are evidence supporting roles for IGFs in the regulation of metabolism. Journal of Endocrinology (1989) 123, 469–475


Sign in / Sign up

Export Citation Format

Share Document